Solvias

Umicore PMC Integrates HTS and Ligand Services from Solvias

Umicore Precious Metals Chemistry (Umicore PMC) has acquired high-throughput screening (HTS) and specialty ligand technologies from Solvias, with services transitioning during 2026.

Solvias Opens New Testing Center in North Carolina, US

Solvias, a Switzerland-headquartered provider of chemistry, manufacturing, and control (CMC) analytics, has opened the first phase of its 50,000-square-foot testing center for biologics and cell and gene therapy in Research Triangle Park (RTP), North Carolina, US.

Solvias Boosts Testing Services with Cergentis Buy

Solvias, a Swiss CDMO serving the pharmaceutical, biotechnology, material science and cosmetic industries, has acquired Dutch biotech Cergentis for an undisclosed sum. The deal bolsters Solvias’ platform of biologics and cell and gene therapy (CGT) testing solutions.

Trend Barometer of Specialty Chemicals Industry

Solvias Acquires Confarma

Hovione, Solvias Announce Collaborate on Improved Drug Solubility

Solvias, Innopharma Labs to Collaborate on PAT Solutions

Solvias Research Team Receives "Sandmeyer Award 2012"

Solvias Research Team Receives Sandmeyer Award 2012

How Solvias Relocated to a New Location without Missing a Beat